Ointment bought at Walmart and Target beneath recall for baby poisoning risk | EUROtoday

Plantimex has issued a recall for its Mamisan Lidocaine Ointment, bought at well-liked retailers equivalent to Walmart and Target, for fears it may result in baby poisonings and deaths.

Approximately 50,330 containers of the ointment have been recalled after regulators found that it was not being bought in child-resistant packaging, as required by regulation.

The lidocaine-containing ointment is bought at Walmart and Target shops throughout the nation and on-line, and poses a critical risk to kids, the U.S. Consumer Product Safety Commission warned in a recall issued final week.

Given the defective packaging, the ointment posed “a risk of serious injury or death from poisoning” if younger kids have been to swallow the contents, regulators mentioned.

Plantimex is required to have child-resistant packaging beneath the Poison Prevention Packaging Act of 1970, which requires related drugs and different hazardous chemical compounds to be bought in packages which are troublesome for younger kids to open however accessible for adults.

The ointment was bought from April 2024 by way of October 2025 for about $10.

Mamisan Pain Relieving Topical Ointment is available in an orange jar with a white steady thread lid that has the Mamisan trademark printed on the lid and the container. The ointment was bought in 3.52-ounce plastic jars. Only jars with UPC code 860006498115 are included within the recall.

As of Monday, no accidents had been reported.

Customers with impacted ointment ought to safe the recalled jars out of sight and attain of kids. Customers can contact Plantimex to obtain a free substitute lid, in keeping with regulators.

Once the product is secured with the substitute lid, customers can use the product as directed.